“…The oral approach has been so far reported in small size studies. The studies suggest that a course of 30 days of oral therapy is both safe an effective and that efficacy is tied to serum blood levels of the drug (Brara et al, 2003;Cernigliaro et al, 2010;Chaves et al, 2005;Fox et al, 2009;Gallo et al, 1999;Guarda et al, 2004;Hausleiter et al, 2004;Munk et al, 2009;Rodriguez et al, 2003;Rodriguez et al, 2005;Rodriguez et al, 2006;Rodriguez, 2009;Rodriguez et al, 2009;Jennings & Kalus 2010;Stojkovic et al, 2010;Waksman et al, 2004;Waksman et al, 2006). Future investigation into the efficacy of oral antiproliferative agents also during the periprocedural period of BMS or DES implantation is still needed.…”